Table 1.
All tablet recipients (N = 6,745) | Tablet usersc(n = 5,503) | |
---|---|---|
% | % | |
Age, mean (SD) | 56 (17) | 56 (16) |
18–44 | 30 | 29 |
45–64c | 35 | 36 |
65b,c | 35 | 36 |
Male | 84 | 84 |
Marriedc | 54 | 55 |
Race/Ethnicity | ||
White, Non-Hispanic | 72 | 73 |
Black, Non-Hispanic | 11 | 11 |
Hispanic | 5 | 5 |
Other | 5 | 5 |
Unknown | 4 | 4 |
Geographic location | ||
Highly rural | 5 | 5 |
Rural | 48 | 48 |
Urban | 47 | 47 |
Distance to nearest VA (mi), mean (SD) | ||
VA primary care | 23 (23) | 23 (23) |
VA secondary carec | 63 (53) | 64 (54) |
VA tertiary carec | 116 (103) | 117 (104) |
Chronic conditions,a,c mean (SD) | 5 (3) | 5 (3) |
Depression | 57 | 57 |
Hypertension | 50 | 50 |
Post-traumatic stress disorder | 48 | 48 |
Low back pain | 37 | 38c |
Diabetes | 26 | 27 |
Arthritis | 18 | 18 |
Chronic Obs pulmonary disease | 16 | 16 |
Ischemic heart disease | 14 | 14 |
Alcohol abuse | 12 | 11c |
Any drug dependence/abuse | 11 | 10c |
Unless otherwise specified.
Count of chronic conditions from a total of 34 included in study; Supplementary Appendix Table 2 lists rates for all conditions assessed.
Tablet use based on calls >2.5 minutes or stop code 179 during 12 months after tablet shipment.
P < .05 when comparing tablet users and non-users (Supplementary Appendix Table 1).